EXPOSURE CONTROL CH 3

  1. ALLERGEN
    • substance, protein or non-protein, capable of inducing allergy or hypersensitivity
    • -inhaled
    • -swallowed
    • -touched
    • -injected
  2. INOCULATION
    • introduction of antigenic material or vaccine
    • usually used to refer to introduction of material into a culture medium.
  3. HYPOALLERGENIC
    • indicating the product will not cause a hypersensitive reaction.
    • may apply to various chemicals, not specified on manufacturer's labels.
  4. LATEX ALLERGY
    an acquired hypersensitivity reaction to the proteins found in natural rubber latex (NRL).
  5. ANTIMICROBIAL SOAP
    a soap containing an active ingredient against skin microorganisms.
  6. OCCUPATIONAL EXPOSURE
    usually skin, eye, mucous membrane, or parenteral contact with blood or other potentially infectious materials that may result from the performance of one's usual duties.
  7. ATOPY
    • clinical hypersensitivity state or allergy with a hereditary predisposition
    • (hay fever, eczema, asthma)
  8. PPD
    Purified Protein Derivative for tuberculin intracutaneous skin test for tuberculosis; positive reaction means previous reaction with Mycobacterium tuberculosis.
  9. BARRIER PROTECTION
    a physical barrier between the patient's body fluids (blood and saliva) and the HCP (healthcare personnel) to prevent disease transmission.
  10. RHINITIS
    • inflammation of the mucous membrane of the nose;
    • possibly from infection by bacteria or virus, or may be a seasonal (hayfever) or non-seasonal allergic reaction.
  11. BARRIERS FOR HCP
    • gloves
    • mask
    • protective eyewear
    • protective clothing (gown)
  12. TOXOID
    • toxin treated by heat or chemical agent to destroy its deleterious properties without destroying its ability to combine or stimulate the function of an antitoxin.
    • ie: tetanus
    • diphtheria
  13. BARRIERS FOR PT
    • protective eyewear
    • head cover during surgeries
    • rubber damn for restorative and sealants
  14. BOOSTER DOSE
    amount of immunogen (vaccine, toxoid, or other antigen preparation), smaller than original amount, injected at an appropriate interval after the primary immunization to sustain the immune response to that immunogen.
  15. TUBERCULIN TEST (MANTOUX)
    • a test for the presence of active or inactive TB
    • a positive test is denoted by redness and induration at the injection site by 48-72 hrs after injection
  16. EXPOSURE INCIDENT
    specific eye, mouth, mucous membrane, nonintact skin, or parenteral contact with blood or other potentially infectious material due to one's performance or unusual professional duties.
  17. VACCINATION
    process of introducing a vaccine into the body to produce immunity to a specific disease
  18. IMMUNIZATION
    to make a someone immune to a particular disease by stimulation with a specific antigen to promote antibody formation in the body.
Author
jackiedh
ID
32135
Card Set
EXPOSURE CONTROL CH 3
Description
KEY TERMS
Updated